Rafferty Asset Management’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295K | Sell |
39,226
-15,716
| -29% | -$118K | ﹤0.01% | 984 |
|
|
2025
Q1 | $416K | Sell |
54,942
-34,716
| -39% | -$263K | ﹤0.01% | 906 |
|
|
2024
Q4 | $1.09M | Sell |
89,658
-25,012
| -22% | -$305K | ﹤0.01% | 774 |
|
|
2024
Q3 | $1.92M | Buy |
114,670
+10,019
| +10% | +$168K | 0.01% | 646 |
|
|
2024
Q2 | $1.83M | Buy |
104,651
+7,596
| +8% | +$132K | 0.01% | 672 |
|
|
2024
Q1 | $1.65M | Buy |
+97,055
| New | +$1.65M | 0.01% | 733 |
|
|
2022
Q2 | – | Sell |
-55,152
| Closed | -$577K | – | 1151 |
|
|
2022
Q1 | $577K | Sell |
55,152
-15,987
| -22% | -$167K | ﹤0.01% | 928 |
|
|
2021
Q4 | $1.1M | Buy |
+71,139
| New | +$1.1M | 0.01% | 827 |
|